Initial studies showed that BAP1 is deleted or mutated in various human cancer cells and that reexpression of BAP1 in H226 human mesothelioma cells, which lack intrinsic BAP1 expression, reverses their tumorigenicity24,25. This evidence concerns the gene BAP1 and mesothelioma.